Autologous stem cell transplant in acute lymphoblastic leukemia: prognostic impact of pre-transplant minimal residual disease

Leuk Lymphoma. 2019 Jan;60(1):274-276. doi: 10.1080/10428194.2018.1468895. Epub 2018 Jun 26.

Affiliation

¹ a Department of Cellular Biotechnologies and Hematology , 'Sapienza' University , Rome , Italy.

PMID: 29944039
DOI: 10.1080/10428194.2018.1468895

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bone Marrow / pathology
Child
Disease-Free Survival
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation*
Humans
Male
Middle Aged
Neoplasm, Residual
Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
Preoperative Period
Prognosis
Retrospective Studies
Risk Assessment / methods
Survival Analysis
Transplantation, Autologous
Young Adult